Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neesha Dhani

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Nature Communications|May 13, 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trialAna C Veneziani, Stephanie Lheureux, Douglas G Millar, et al.
JTO Clinical and Research Reports|April 17, 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint InhibitorsAbdulrahman Alghabban, Lucy Corke, Hans Katzberg, et al.
Obstetrics and Gynecology International|June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary PerspectiveYeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort StudyGordon Taylor Moffat, Zachary Coyne, Hamzeh Albaba, et al.
Journal of Oncology Practice|September 25, 2019
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic CancerYeh Chen Lee, Nazlin Jivraj, Lisa Wang, et al.
Molecular Carcinogenesis|May 2, 2024
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltrationAlice N Weaver, Wade T Iams, Jong Chul Park, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 26, 2018
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreasBenjamin P T Loveday, Nathan Zilbert, Pablo E Serrano, et al.
Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Nature Communications|May 13, 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trialAna C Veneziani, Stephanie Lheureux, Douglas G Millar, et al.
JTO Clinical and Research Reports|April 17, 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint InhibitorsAbdulrahman Alghabban, Lucy Corke, Hans Katzberg, et al.
Obstetrics and Gynecology International|June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary PerspectiveYeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort StudyGordon Taylor Moffat, Zachary Coyne, Hamzeh Albaba, et al.
Journal of Oncology Practice|September 25, 2019
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic CancerYeh Chen Lee, Nazlin Jivraj, Lisa Wang, et al.
Molecular Carcinogenesis|May 2, 2024
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltrationAlice N Weaver, Wade T Iams, Jong Chul Park, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 26, 2018
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreasBenjamin P T Loveday, Nathan Zilbert, Pablo E Serrano, et al.
Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
Pageof 5